407,60 €
452,89 €
-10% with code: EXTRA
Drug Discovery for Leishmaniasis
Drug Discovery for Leishmaniasis
407,60
452,89 €
  • We will send in 10–14 business days.
From a human health perspective, leishmaniasis is among the most important protozoan diseases, superseded only by malaria. Between 10 and 12 million people are affected by the disease and with no known vaccine, the development of new drugs is urgently required. This volume provides a perspective of current treatments and their challenges as well as discussing emerging strategies and methodologies that will drive new drug development for this 'neglected' disease.
  • Publisher:
  • ISBN-10: 1782628894
  • ISBN-13: 9781782628897
  • Format: 16.3 x 23.4 x 2.8 cm, hardcover
  • Language: English
  • SAVE -10% with code: EXTRA

Drug Discovery for Leishmaniasis (e-book) (used book) | bookbook.eu

Reviews

Description

From a human health perspective, leishmaniasis is among the most important protozoan diseases, superseded only by malaria. Between 10 and 12 million people are affected by the disease and with no known vaccine, the development of new drugs is urgently required. This volume provides a perspective of current treatments and their challenges as well as discussing emerging strategies and methodologies that will drive new drug development for this 'neglected' disease.

EXTRA 10 % discount with code: EXTRA

407,60
452,89 €
We will send in 10–14 business days.

The promotion ends in 18d.01:02:02

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 4,53 Book Euros!?
  • Publisher:
  • ISBN-10: 1782628894
  • ISBN-13: 9781782628897
  • Format: 16.3 x 23.4 x 2.8 cm, hardcover
  • Language: English English

From a human health perspective, leishmaniasis is among the most important protozoan diseases, superseded only by malaria. Between 10 and 12 million people are affected by the disease and with no known vaccine, the development of new drugs is urgently required. This volume provides a perspective of current treatments and their challenges as well as discussing emerging strategies and methodologies that will drive new drug development for this 'neglected' disease.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)